Document Type

Journal Article

Publication Title

BJU International

Volume

127

Issue

S1

First Page

30

Last Page

31

PubMed ID

33565238

Publisher

Wiley

School

Exercise Medicine Research Institute

Funders

National Health and Medical Research Council

Grant Number

NHMRC Number : APP1098042

Comments

Dunn, J., Heathcote, P., & Chambers, S. K. (2021). Prostate cancer survivorship care: If not now, when?. BJU International, 127(S1), 30-31. https://doi.org/10.1111/bju.15358

Abstract

Prostate cancer is the most common cancer diagnosed in Australian men, excluding non-melanoma skin cancer, and it is estimated that there are over 220 000 Australian men living with a diagnosis of prostate cancer [1]. Survival for men with prostate cancer is excellent in countries that have accessible screening and treatment services, and in Australia 5-year relative survival is over 95% [1]. High incidence, coupled with improving long-term survival, leads to a correspondingly high prevalence rate and high community disease burden. Many men with prostate cancer experience long-term decrements in their mental and physical quality of life, overall they have a greater suicide risk than their non-cancer peers, and unmet supportive care needs are pervasive [2]. In this context, survivorship care for men with prostate cancer is crucial in both the short and long term. The recent development of a Prostate Cancer Survivorship Essentials Framework in the Australian and New Zealand setting provides an example of a regional response to this issue that delivers guidance for policy makers, clinicians, community and consumers on what is essential for step change in prostate cancer survivorship outcomes [3].

DOI

10.1111/bju.15358

Creative Commons License

Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.

Share

 
COinS